Ketamine depot (Alar Pharmaceuticals)

N/A

Report date: 2025/05/15 20:00:08
NME

Base Information

Drug NameKetamine depot (Alar Pharmaceuticals)
Drug Alias NameDepot ketamine formulation (Alar Pharmaceuticals)ALA-3000
ClassificationSmall molecules
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonistsDopamine receptors agonistsNicotinic receptors modulators +[5] 
TargetsGlutamate receptor ionotropic AMPADopamine receptorsNicotinic receptors +[5] 
Therapy Area/IndicationsDepressive Disorder, Treatment-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlar Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlar Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A